Clinical Trials Browser

Phase 1 × Maximum Tolerated Dose × Clear all

NCT06976892 2025-08-13

IDOL

Phase 1 Recruiting

Ovarian Neoplasms

NCT05976555 2025-06-11

Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma

Phase 1 Not yet recruiting

Multiple Myeloma

NCT02994953 2024-09-20

COMBO

Phase 1 Terminated

52 enrolled 34 charts

Other solid neoplasm

Advanced Solid Tumors